Purchase Order 75N93021P01406
Award Date 9/13/21
Potential Completion Date 7/7/22
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Allergy and Infectious Diseases awarded a $17,013.02 firm fixed-price purchase order to Qiagen, LLC for the QIASEQ FastSelect 5S/16S/23S Kit (384). This contract, awarded on September 16, 2021, with an ultimate completion date of September 24, 2021, represents a straightforward procurement of specialized molecular biology reagents used for ribosomal RNA depletion and sample preparation in next-generation sequencing applications. The award includes no set-aside...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order valued at $13,166 to Qiagen, LLC of Germantown, Maryland. The one-year contract provides full agreement service for two QIACUBE HT/QIAXTRACTOR platforms from July 1, 2023 to June 30, 2024. Qiagen, LLC is a subsidiary of Qiagen N.V. and will perform the entirety of the contract within the United States. The award is likely in...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $10,736.64 on August 11, 2020. The order covers ten HISPEED Plasmid Maxi Kits at $252.00 each, priced on a firm fixed-price basis. Work is performed in Germantown, Maryland, with an ultimate completion date of September 6, 2020. No small business set-aside applies.</p>
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for an annual service agreement for nucleic acid extraction equipment, valued at $10,410.00, with an award date of May 15, 2020 and completion date of May 14, 2021. Work is performed in Germantown, Maryland. The order is priced on a firm fixed price basis with no set-aside designation.</p>
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for RNA and DNA screening kits valued at $4,491.12 on August 24, 2017, with an ultimate completion date of August 31, 2017. The order carries firm fixed pricing and no set-aside designation. Place of performance is Valencia, California.</p>
- Qiagen, LLC has been awarded a firm fixed price purchase order totaling $18,780.30 by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract is for an annual service agreement to provide support for Qiagen's QIAcuity Eight Digital PCR System in Bethesda, Maryland through February 27, 2025. No set-aside designation was used for this award to support the agency's research into allergies and infectious...
- <p>The National Institutes of Health Office of Acquisitions and Grants issued a purchase order to Qiagen, LLC for $4,566.00 on August 6, 2026 for QIAcube preventative maintenance. Performance occurs in Germantown, Maryland with completion due August 6, 2027. The order is firm fixed price with no set-aside applied.</p>
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, awarded a $4,094.11 firm-fixed-price purchase order to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. This award does not have a set-aside designation. The award supports Qiagen's provision of products and services to NIAID, such as DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, and bioinformatics...
- This is a firm fixed-price purchase order awarded to Qiagen, LLC by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The contract has a ceiling value of $16,101.84 and a period of performance through May 11, 2024. The award does not have a set-aside designation. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V. Qiagen provides a range of products and services to support federal...
- This is a $14,088 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of specialized scientific equipment and reagents. The contract is for the supply of QIACUBE HT instruments and related equipment and services. Qiagen is an experienced federal contractor, holding several indefinite delivery vehicles (IDVs) with agencies like the FBI and Department of Veterans...
The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $13,936.20 in QIAcube-compatible QIAseq sequencing kits on September 13, 2021, with ultimate completion on July 7, 2022. The order was issued to de-obligate unexpiring fiscal year 2021 funds in accordance with 31 U.S.C. Section 1552(a) ahead of the September 30, 2026 period-of-availability close. Performance takes place in Germantown, Maryland. The purchase order carries firm fixed price pricing and no set-aside designation.
Generated 7/2/26, 1:09 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($30) | 3/2/26 | |
| P00001 | Other Administrative Action | $0 | 7/7/22 | |
| Not listed | Not listed | $14.0k | 9/13/21 |